tiprankstipranks
Trending News
More News >

Moolec Science Completes Strategic Business Combination to Enhance Life Sciences and Food-Tech Leadership

Story Highlights
  • Moolec Science completed a strategic merger with Bioceres, Gentle Tech, and Nutrecon.
  • The merger strengthens Moolec’s position in sustainable life sciences and food-tech.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Moolec Science Completes Strategic Business Combination to Enhance Life Sciences and Food-Tech Leadership

Don’t Miss TipRanks’ Half-Year Sale

An update from Moolec Science ( (MLEC) ) is now available.

On June 17, 2025, Moolec Science announced the successful completion of its strategic business combination with Bioceres Group, Gentle Technologies Corp, and Nutrecon LLC, enhancing its position in the life sciences and food-tech sectors. This merger consolidates Moolec’s capabilities in food ingredients, ag-biologicals, precision fermentation, and biomaterials, positioning it as a leader in sustainable solutions. The transaction, approved by shareholders on June 16, 2025, involves equity exchanges and the appointment of Alejandro Antalich as CEO, who brings extensive experience in biotechnology and life sciences.

The most recent analyst rating on (MLEC) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on Moolec Science stock, see the MLEC Stock Forecast page.

Spark’s Take on MLEC Stock

According to Spark, TipRanks’ AI Analyst, MLEC is a Neutral.

The overall score reflects significant financial challenges due to high leverage, negative profitability, and cash flow issues. Mixed technical indicators and a negative P/E ratio further highlight uncertainties in the stock’s potential for growth.

To see Spark’s full report on MLEC stock, click here.

More about Moolec Science

Moolec Science is a science-based ingredient company specializing in Molecular Farming technology for the food and dietary supplementation markets. The company focuses on engineering plants with animal protein genes to create unique food ingredients, aiming to combine the cost benefits of plant-based solutions with the nutritional and functional advantages of animal-based products. Moolec operates in the United States, Europe, and South America and has developed a robust international patent portfolio.

Average Trading Volume: 7,205

Technical Sentiment Signal: Sell

Current Market Cap: $28.49M

For a thorough assessment of MLEC stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1